Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 24
Summary
- Conditions
- Bladder Cancer
- Carcinoma Non-small-cell Lung
- Mesothelioma
- Ovarian Cancer
- Peritoneal Cancer
- Thymoma
- Thymus Cancer
- Uterine Cervical Cancer
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03023319
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Nagla Karim, MD Augusta University Georgia Cancer Center